Mismatched Related vs. Matched Unrelated Donor

A Multi-Center, Phase 3, Randomized Trial of Matched Unrelated Donor (MUD) Versus HLA-Haploidentical Related (Haplo) Myeloablative Hematopoietic Cell Transplantation for Children, Adolescents, and Young Adults (AYA) With Acute Leukemia or Myelodysplastic Syndrome (MDS)

More Information

Trial Status
Accepting patients
Trial Phase
Phase 3
Enrollment
435 patients (estimated)
Sponsors
Children's Oncology Group
Tags
Allogeneic Stem Cell Transplant, Chemotherapy, Monoclonal Antibody, CD20, Radiation Therapy, Randomization
Trial Type
Treatment
Last Update
2 months ago
SparkCures ID
1619
NCT Identifier
NCT05457556

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print a patient-friendly report to share with your patient.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.